Stonegate Capital Partners has updated its coverage on Viemed Healthcare, Inc. (NASDAQ: VMD), detailing the company's financial performance for fiscal year 2025 and outlining key strategic developments. Viemed reported net revenue growth of 21% year-over-year to $270.3 million, generating $14.9 million in net income and achieving a record adjusted EBITDA of $61.4 million. This growth was driven by continued platform momentum and contributions from the Lehan’s acquisition, alongside broader industry tailwinds from the shift to in-home care and accelerating adoption of sleep and resupply services.
The company faced a key headwind from the updated National Coverage Determination (NCD), which introduced additional documentation requirements and tightened coverage criteria, temporarily moderating ventilator patient growth. However, Stonegate notes that reimbursement levels remained unchanged and ventilator activity has already begun to normalize. Viemed ended the fiscal year with free cash flow up 141% year-over-year, reflecting strong operational efficiency. For more detailed financial data and analysis, refer to the full announcement available here.
Stonegate's analysis highlights several important trends for Viemed's future. Sleep and resupply services are now overtaking ventilation in terms of growth, which improves the quality of recurring revenue and reduces regulatory sensitivity. This shift is significant as it diversifies Viemed's revenue streams away from more volatile segments. The acquisition of Lehan’s has broadened Viemed's commercial exposure, diversified its payor base, and created a longer runway for scaled growth, enhancing the company's market position.
Despite some margin mix pressure from these transitions, Stonegate indicates that Viemed's fiscal year 2026 guidance and current valuation suggest that durable growth remains underappreciated by the market. The firm's coverage update emphasizes the strategic importance of Viemed's diversification efforts and its ability to navigate regulatory changes while maintaining financial health. The full report, including additional insights and downloadable materials, can be accessed via Stonegate's platform here.
This update matters for investors and industry observers as it underscores Viemed's resilience in adapting to regulatory shifts and capitalizing on growing demand for in-home healthcare services. The company's focus on sleep and resupply, coupled with the integration of Lehan’s, positions it to benefit from long-term trends toward decentralized care, potentially offering more stable and predictable growth. For stakeholders, this signals Viemed's potential to sustain performance in a dynamic healthcare landscape, making it a noteworthy case study in the home medical equipment sector.
